B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
Objectivechordomas are rare bone tumors with few therapeutic options. Skull base and sacrum are the two most common origin sites. Immunotherapies are emerging as the most promising approaches to fight various cancers. This study tends to identify new cell surface targets for immunotherapeutic option...
Saved in:
Main Authors: | Cheng Long, Gaowei Li, Chengyun Zhang, Tao Jiang, Yanjun Li, Xin Duan, Gang Zhong |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5a57d5834a2c47fe85e1b1e834f5dd6c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma
by: Chubei Teng, et al.
Published: (2021) -
Skull base chordomas review of current treatment paradigms
by: Dan Yaniv, et al.
Published: (2020) -
Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy
by: Andreas Köthe, et al.
Published: (2021) -
Gluteus maximus metastasis from sacrococcygeal chordoma: A case report
by: Wanchen Liu, MD, et al.
Published: (2022) -
Microscopic and Endoscopic Transoral Approaches for the Management of Craniocervical Chordomas
by: Mohammad Fathy Eissa, et al.
Published: (2021)